Type 2 diabetes mellitus is a chronic metabolic disease resulting from insulin resistance and progressively reduced insulin secretion, which leads to impaired glucose utilization, dyslipidemia and hyperinsulinemia and progressive pancreatic beta cell dysfunction. This evidence concerns the gene INS and type 2 diabetes mellitus.